Today, the U.S. Food and Drug Administration approved Eucrisa (crisaborole), a topical treatment for children and adults with mild to moderate atopic dermatitis (AD). Eucrisa works differently than other topical treatments on the market. It is not a steroid or a topical calcineurin inhibitor.
These breakthroughs are leading to new treatments. The U.S. Food and Drug Administration (FDA) has approved two medications, and more than 40 possible
The FDA recently approved a novel drug, crisaborole (Eucrisa), for the. and inflammation caused by atopic dermatitis, which is also known as eczema.
Compare risks and benefits of common medications used for Eczema. Find the most popular drugs, view ratings, user reviews, and more.